Developing
Health·6/3/2026AI summary
41-year-old mother with metastatic breast cancer overcomes tumor's changing nature with new drugs
A 41-year-old mother, "Xiao Ya," successfully battled metastatic breast cancer whose cells changed type three times, from HER2-positive to triple-negative, and finally to HER2-low-positive. New precision drugs, including ADC medications, have helped her overcome the evolving tumor. However, Taiwan's National Health Insurance does not yet cover these treatments for advanced and metastatic HER2-low-positive patients, raising concerns about unequal access to care.
自
自由时报